These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8525049)

  • 1. T-cell costimulation via CD28-CD80/CD86 and CD40-CD40 ligand interactions.
    Somoza C; Lanier LL
    Res Immunol; 1995; 146(3):171-6. PubMed ID: 8525049
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI; Wofsy D
    Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
    Vonderheide RH; Butler MO; Liu JF; Battle TE; Hirano N; Gribben JG; Frank DA; Schultze JL; Nadler LM
    Int J Oncol; 2001 Oct; 19(4):791-8. PubMed ID: 11562757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
    van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
    Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
    [No Abstract]   [Full Text] [Related]  

  • 7. CD28-CD80/86 and CD40-CD40L Interactions Promote Thymic Tolerance by Regulating Medullary Epithelial Cell and Thymocyte Development.
    Williams JA; Tai X; Hodes RJ
    Crit Rev Immunol; 2015; 35(1):59-76. PubMed ID: 25746048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
    Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
    Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cell interactions regulate dendritic cell-dependent HIV-1 production in CD4+ T lymphocytes.
    Pinchuk LM; Polacino PS; Agy MB; Klaus SJ; Clark EA
    Adv Exp Med Biol; 1995; 378():461-3. PubMed ID: 8526118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
    Lane P
    Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory molecules (CD80 and CD86) on Reed-Sternberg cells are associated with the proliferation of background T cells in Hodgkin's disease.
    Nozawa Y; Wakasa H; Abe M
    Pathol Int; 1998 Jan; 48(1):10-4. PubMed ID: 9589458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
    Slavik JM; Hutchcroft JE; Bierer BE
    J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
    Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
    Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
    Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
    Linsley PS; Ledbetter J; Peach R; Bajorath J
    Res Immunol; 1995; 146(3):130-40. PubMed ID: 8525042
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
    Yen MH; Lepak N; Swain SL
    J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F; Csernok E; Wang G; Gross WL
    Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.